REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dawnrays Pharmaceutical Holdings Limited (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dawnrays Pharmaceutical Holdings Limited Profile Updated: October 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Dawnrays Pharmaceutical Holdings Limited is an investment holding company primarily engaged in the development, manufacture and sale of non-patented pharmaceutical medicines including intermediate pharmaceutical, bulk medicines and finished drugs. The company was incorporated in 2002 and is headquartered in Hong Kong.

Headquarters
Units 3001-02, 30/F, Cnt Tower, 338 Hennessy Road, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the Dawnrays Pharmaceutical Holdings Limited report to view the information.

Basic Information
Total Employees:
Purchase the Dawnrays Pharmaceutical Holdings Limited report to view the information.
Outstanding Shares:
Purchase the Dawnrays Pharmaceutical Holdings Limited report to view the information.
Registered Capital:
Purchase the Dawnrays Pharmaceutical Holdings Limited report to view the information.
Financial Auditors:
Purchase the Dawnrays Pharmaceutical Holdings Limited report to view the information.
Incorporation Date:
September 20, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
6.45%
Purchase this report to view the information.
5.16%
Purchase this report to view the information.
0.01%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Dawnrays Biotechnology Capital (Asia) Limited
100%
Dawnrays International Company Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Dawnrays Pharmaceutical Holdings Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-11.15%▼
Total operating revenue
8.4%▲
Operating profit (EBIT)
69.63%▲
EBITDA
39.4%▲
Net Profit (Loss) for the Period
93.41%▲
Total assets
13.7%▲
Total equity
16.24%▲
Operating Profit Margin (ROS)
44.73%▲
Net Profit Margin
46.02%▲
Return on Equity (ROE)
6%▲
Debt to Equity Ratio
4.56%▲
Quick Ratio
0.8%▲
Cash Ratio
0.57%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo